Immuneering Corporation - Class A Common Stock (NQ:IMRX)
3.370
-0.160
(-4.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 30, 2025
Add to My Watchlist
Headline News about Immuneering Corporation - Class A Common Stock![]()
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
September 02, 2022
Via Benzinga
![]()
Immuneering Shares Climb After Pursuing FDA Nod For RAS Mutant Tumor Study
September 02, 2022
Via Benzinga
![]()
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
September 02, 2022
Via Benzinga
![]()
Why This Small-Cap Stock Is Gaining More Than 10% Today?
July 08, 2022
Via Benzinga
![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|